164 related articles for article (PubMed ID: 24185966)
1. Effects of tetrandrine on glioma cell malignant phenotype via inhibition of ADAM17.
Wu Z; Wang G; Xu S; Li Y; Tian Y; Niu H; Yuan F; Zhou F; Hao Z; Zheng Y; Li Q; Wang J
Tumour Biol; 2014 Mar; 35(3):2205-10. PubMed ID: 24185966
[TBL] [Abstract][Full Text] [Related]
2. Dihydroartemisinin suppresses glioma proliferation and invasion via inhibition of the ADAM17 pathway.
Chen J; Chen X; Wang F; Gao H; Hu W
Neurol Sci; 2015 Mar; 36(3):435-40. PubMed ID: 25301262
[TBL] [Abstract][Full Text] [Related]
3. ADAM17 promotes glioma cell malignant phenotype.
Zheng X; Jiang F; Katakowski M; Lu Y; Chopp M
Mol Carcinog; 2012 Feb; 51(2):150-64. PubMed ID: 21480393
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of ADAM17 reduces hypoxia-induced brain tumor cell invasiveness.
Zheng X; Jiang F; Katakowski M; Kalkanis SN; Hong X; Zhang X; Zhang ZG; Yang H; Chopp M
Cancer Sci; 2007 May; 98(5):674-84. PubMed ID: 17355261
[TBL] [Abstract][Full Text] [Related]
5. Tetrandrine suppresses proliferation, induces apoptosis, and inhibits migration and invasion in human prostate cancer cells.
Liu W; Kou B; Ma ZK; Tang XS; Lv C; Ye M; Chen JQ; Li L; Wang XY; He DL
Asian J Androl; 2015; 17(5):850-3. PubMed ID: 25677131
[TBL] [Abstract][Full Text] [Related]
6. Tetrandrine inhibits migration and invasion of rheumatoid arthritis fibroblast-like synoviocytes through down-regulating the expressions of Rac1, Cdc42, and RhoA GTPases and activation of the PI3K/Akt and JNK signaling pathways.
Lv Q; Zhu XY; Xia YF; Dai Y; Wei ZF
Chin J Nat Med; 2015 Nov; 13(11):831-841. PubMed ID: 26614458
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor Sp1 induces ADAM17 and contributes to tumor cell invasiveness under hypoxia.
Szalad A; Katakowski M; Zheng X; Jiang F; Chopp M
J Exp Clin Cancer Res; 2009 Sep; 28(1):129. PubMed ID: 19772640
[TBL] [Abstract][Full Text] [Related]
8. ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation.
Zheng X; Jiang F; Katakowski M; Zhang ZG; Lu QE; Chopp M
Cancer Biol Ther; 2009 Jun; 8(11):1045-54. PubMed ID: 19395875
[TBL] [Abstract][Full Text] [Related]
9. Tetrandrine inhibits glioma stem-like cells by repressing β-catenin expression.
Zhang Y; Wen YL; Ma JW; Ye JC; Wang X; Huang JX; Meng CY; Xu XZ; Wang SX; Zhong XY
Int J Oncol; 2017 Jan; 50(1):101-110. PubMed ID: 27909720
[TBL] [Abstract][Full Text] [Related]
10. MiR-145 reduces ADAM17 expression and inhibits in vitro migration and invasion of glioma cells.
Lu Y; Chopp M; Zheng X; Katakowski M; Buller B; Jiang F
Oncol Rep; 2013 Jan; 29(1):67-72. PubMed ID: 23076445
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of anti-tumor effects by tetrandrine treatment in HepG2 cells.
Cheng Z; Wang K; Wei J; Lu X; Liu B
Phytomedicine; 2010 Nov; 17(13):1000-5. PubMed ID: 20554191
[TBL] [Abstract][Full Text] [Related]
12. Tumorigenicity of cortical astrocyte cell line induced by the protease ADAM17.
Katakowski M; Jiang F; Zheng X; Gutierrez JA; Szalad A; Chopp M
Cancer Sci; 2009 Sep; 100(9):1597-604. PubMed ID: 19515085
[TBL] [Abstract][Full Text] [Related]
13. Tetrandrine suppresses cervical cancer growth by inducing apoptosis in vitro and in vivo.
Zhang H; Xie B; Zhang Z; Sheng X; Zhang S
Drug Des Devel Ther; 2019; 13():119-127. PubMed ID: 30587932
[TBL] [Abstract][Full Text] [Related]
14. Tetrandrine suppresses human glioma growth by inhibiting cell survival, proliferation and tumour angiogenesis through attenuating STAT3 phosphorylation.
Ma JW; Zhang Y; Li R; Ye JC; Li HY; Zhang YK; Ma ZL; Li JY; Zhong XY; Yang X
Eur J Pharmacol; 2015 Oct; 764():228-239. PubMed ID: 26086859
[TBL] [Abstract][Full Text] [Related]
15. Tetrandrine suppresses metastatic phenotype of prostate cancer cells by regulating Akt/mTOR/MMP-9 signaling pathway.
Kou B; Liu W; He W; Zhang Y; Zheng J; Yan Y; Zhang Y; Xu S; Wang H
Oncol Rep; 2016 May; 35(5):2880-6. PubMed ID: 26935264
[TBL] [Abstract][Full Text] [Related]
16. ADAM17 mediates hypoxia-induced drug resistance in hepatocellular carcinoma cells through activation of EGFR/PI3K/Akt pathway.
Wang XJ; Feng CW; Li M
Mol Cell Biochem; 2013 Aug; 380(1-2):57-66. PubMed ID: 23625205
[TBL] [Abstract][Full Text] [Related]
17. Tetrandrine inhibits the proliferation of human osteosarcoma cells by upregulating the PTEN pathway.
Tian DD; Zhang RX; Wu N; Yuan W; Luo SH; Chen HQ; Liu Y; Wang Y; He BC; Deng ZL
Oncol Rep; 2017 May; 37(5):2795-2802. PubMed ID: 28393256
[TBL] [Abstract][Full Text] [Related]
18. Sensitization of cerebral tissue in nude mice with photodynamic therapy induces ADAM17/TACE and promotes glioma cell invasion.
Zheng X; Jiang F; Katakowski M; Zhang X; Jiang H; Zhang ZG; Chopp M
Cancer Lett; 2008 Jul; 265(2):177-87. PubMed ID: 18358600
[TBL] [Abstract][Full Text] [Related]
19. TGF-β1 promotes motility and invasiveness of glioma cells through activation of ADAM17.
Lu Y; Jiang F; Zheng X; Katakowski M; Buller B; To SS; Chopp M
Oncol Rep; 2011 May; 25(5):1329-35. PubMed ID: 21359495
[TBL] [Abstract][Full Text] [Related]
20. [Effects of tetrandrine on proliferation, migration, and invasion of glioblastoma cells].
Lu XY; Wang ZZ; Wan SC; Zhao EH; Cui HJ
Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(24):6520-6529. PubMed ID: 34994145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
